Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-14-006918
Filing Date
2014-06-27
Accepted
2014-06-27 15:15:19
Documents
14

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2141372
2 filename2.htm EX-10 32255
3 filename3.htm EX-10 33791
4 GRAPHIC g705598img2.jpg GRAPHIC 10204
5 GRAPHIC g705598g01c14.jpg GRAPHIC 40420
6 GRAPHIC g705598g09d27.jpg GRAPHIC 42781
7 GRAPHIC g705598g12o36.jpg GRAPHIC 42084
8 GRAPHIC g705598g15l70.jpg GRAPHIC 12530
9 GRAPHIC g705598g40f02.jpg GRAPHIC 24015
10 GRAPHIC g705598g57f46.jpg GRAPHIC 41330
11 GRAPHIC g705598g62k76.jpg GRAPHIC 20634
12 GRAPHIC g705598g93s13.jpg GRAPHIC 55510
13 GRAPHIC g705598img1.jpg GRAPHIC 5051
14 filename14.htm COVER 32266
  Complete submission text file 0000950123-14-006918.txt   2648071
Mailing Address 1 Broadway 14TH FLOOR Cambridge MA 02142
Business Address 1 Broadway 14TH FLOOR Cambridge MA 02142 617-225-4348
Tokai Pharmaceuticals Inc (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-00590 | Film No.: 14945777
SIC: 2834 Pharmaceutical Preparations